NasdaqGS:ANABBiotechs
AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts
AnaptysBio (NasdaqGS:ANAB) has approved a change in its fiscal year-end from December 31 to June 30.
The new fiscal year-end is expected to affect the timing of future financial reports and corporate disclosures.
The decision reflects an adjustment to the company’s reporting calendar and financial planning framework.
AnaptysBio, trading at $51.24, has recorded very large share price gains over the past year, with the stock up 261.4% over that period and 220.2% over five years. The...